Purchase Order 75N92023P00161
Award Date 5/2/23
Potential Completion Date 5/1/25
Potential Value $669K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute (NHGRI) awarded a firm-fixed-price purchase order to Norgen Biotek Corp, a Canadian for-profit manufacturer, to provide exosome extraction services for future RNA sequencing. The potential value of the contract is $165,000.00, and the period of performance is from the award date of June 25, 2019, to the completion date of June 24, 2021. Norgen Biotek Corp has previously provided...
- The National Institutes of Health (NIH) National Human Genome Research Institute (NHGRI) awarded a $119,200.00 firm fixed-price purchase order to Norgen Biotek Corp, a Canadian for-profit manufacturer, to provide exosome extraction services in support of future RNA sequencing work for NHGRI. This award is not associated with a set-aside program. Through previous federal contracts valued between $16,464 and $668,710, Norgen Biotek has provided similar exosome and extracellular RNA extraction,...
- The National Human Genome Research Institute (NHGRI), part of the National Institutes of Health under the Department of Health and Human Services, awarded a $156,600 firm fixed-price purchase order to Norgen Biotek Corp for small RNA characterization of urinary exosomes. This is a new purchase order with no set-aside designation, making it open to competition among all qualified contractors. Work will be performed at Norgen Biotek's facilities in Bethesda, Maryland, with an ultimate completion...
- This is a purchase order contract awarded by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), to Norgen Biotek Corp, a Canadian for-profit manufacturer of biotechnology products and services. The contract, valued at $149,840, is for the provision of exosome and extracellular RNA extraction, isolation, purification, and sequencing services to support clinical research studies at NIH. Norgen Biotek has previously been awarded over $1 million in...
- The U.S. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has awarded a $16,821.83 firm fixed-price purchase order to Norgen Biotek Corp, a Canadian for-profit manufacturer, to provide exosomal RNA purification services. This order, which does not have a set-aside designation, supports unspecified NIDDK and National Heart, Lung and Blood Institute clinical trials, as well as future RNA sequencing work for the National Human Genome Research Institute (NHGRI). Norgen Biotek...
- This is a $37,814 firm fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Reprocell U.S.A., Inc. The contract is for the extraction of total RNA from whole blood samples in support of research activities at the National Human Genome Research Institute (NHGRI), another NIH agency. The contract was awarded on July 10, 2020 through full and open competition, with a period of performance ending on March 31,...
- This firm-fixed-price purchase order was awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services, to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics, scientific equipment, and bioinformatics solutions. The $24,882.55 contract is for the NHLBI's Laboratory of Applied Precision Omics to acquire Qiagen's QIAsymphony DSP Circulating DNA Kit to isolate cell-free DNA from plasma samples...
- The Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute awarded a $11,640 purchase order to Audubon Bioscience Company of Houston, Texas for blood plasma. The firm fixed price contract runs from August 4, 2023 through September 29, 2023 to support the agency's genomic research efforts. No subcontractors or set aside designations were identified. The National Human Genome Research Institute conducts large-scale sequencing and analysis...
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $45,183.92 purchase order to 10X Genomics, Inc. doing business as 10X Genomics. The firm fixed price contract is for the delivery of library construction kits to support biomedical research efforts. Performance will occur at the prime contractor's facility in Pleasanton, California over the one year period from April 2021 through April 2022. No set aside designation or...
- This is a $24,978.80 firm fixed-price purchase order awarded by the National Heart Lung and Blood Institute, part of the Department of Health and Human Services, to Qiagen, LLC, a foreign-owned for-profit manufacturer of molecular diagnostic products. The contract requires Qiagen to provide QIAsymphony DSP circulating DNA kits to isolate cell-free DNA from plasma samples from lung transplant patients. This is likely in support of the agency's biomedical research and public health programs. The...